Results 21 to 30 of about 2,332 (167)

Pioderma gangrenoso como manifestación cutánea de granulomatosis con poliangeítis. A propósito de un caso

open access: yesRevistas Argentina de Medicina, 2022
La granulomatosis con poliangeítis es una vasculitis necrosante de causa desconocida que afecta a vasos de mediano y pequeño calibre. Se asocia a anticuerpos de neutrófilo (ANCA). Afecta con más frecuencia el aparato respiratorio y renal.
Carla Romina Lamolla
doaj   +2 more sources

Wegener granulomatosis as possible cause of vertigo: case report and review

open access: yesB-ENT, 2015
Wegener granulomatosis as possible cause of vertigo: case report and review. Objective: Wegener granulomatosis (WG) or granulomatosis with polyangiitis (GPA) is a multi-system necrotizing granulomatous vasculitis that classically affects the upper ...
J. Goderis   +3 more
doaj   +2 more sources

An Atypical Presentation of Wegener's Granulomatosis in a Child [PDF]

open access: yesJournal of Krishna Institute of Medical Sciences University, 2016
Wegener`s granulomatosis is an autoimmune small vessel necrotising vasculitis associated with both granulomatosis and polyangiitis. While its standard form involves the upper and lower respiratory tracts and kidneys, it may essentially involve any ...
Rohit Bannerji   +3 more
doaj  

Chronic meningitis with multiple cranial neuropathies: A rare initial presentation of Wegener′s granulomatosis

open access: yesAnnals of Indian Academy of Neurology, 2013
Wegener′s granulomatosis (WG) is a systemic necrotizing vasculitis that affects the small blood vessels. It mainly affects the upper and lower respiratory tract and kidneys.
Vikas Gupta   +4 more
doaj   +1 more source

Multiple cavitary pulmonary nodules in association with pyoderma gangrenosum: case report Múltiplos nódulos pulmonares cavitados em associação com pioderma gangrenoso: relato de caso

open access: yesAnais Brasileiros de Dermatologia, 2012
Pyoderma gangrenosum is a rare neutrophilic disease of unknown origin that is associated with systemic diseases in 50% of cases. It is characterized by erythematous-violaceous nodular lesions that quickly progress to painful ulcers, with undermined edges,
Maraya de Jesus Semblano Bittencourt   +5 more
doaj   +1 more source

Massive, life-threatening hemoptysis due to localized granulomatosis with polyangiitis

open access: yesJournal of Cardiothoracic Surgery, 2023
Massive hemoptysis may be related to a wide spectrum of diseases whose differential diagnosis can be challenging, also due to the medical emergency condition.
Eleonora Coviello   +4 more
doaj   +1 more source

Granulomatose de Wegener – Envolvimento otológico, nasal, laringotraqueal e pulmonar

open access: yesRevista Portuguesa de Pneumologia, 2009
Resumo: A granulomatose de Wegener é uma vasculite sistémica rara e idiopática caracterizada pelo atingimento dos pequenos vasos. A doença atinge, preferencial-mente, as vias aérea superior e inferior e os rins, levando à formação de granulomas e
Sandra Figueiredo   +7 more
doaj   +1 more source

Granulomatosis with polyangiitis patient with retinitis as an initial manifestation

open access: yesThe Pan-American Journal of Ophthalmology, 2022
The German pathologist Friedrich Wegener described granulomatosis with polyangiitis (GPA), formerly known as Wegener's Granulomatosis, in 1936. Lesions are inflammatory, and typically include vasculitis, necrosis, and granulomatous changes.
Valdez Melo Dos Anjos Filho   +3 more
doaj   +1 more source

Treatment of Wegener’s granulomatosis [PDF]

open access: yesReumatismo, 1993
Treatment and outcome of 111 patients who fell ill with Wegener's granulomatosis (WG) between 1966 and 1990 were analysed retrospectively. Two regimens of treatment were distinguished: "conventional" treatment, i.e. daily application of cyclophosphamide/corticosteroids (FAUCI scheme) or azathioprine/corticosteroids or corticosteroids alone, and "stage ...
Lutz Briedigkeit   +5 more
openaire   +6 more sources

Biosimilar Rituximab in ANCA‐Associated Vasculitis Compared to the Originator: A Multicenter Cohort Study

open access: yesACR Open Rheumatology, Volume 8, Issue 8, August 2026.
Objective To evaluate the six‐month effectiveness and safety of rituximab biosimilars compared to the originator in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA), and outcomes following originator to biosimilar switching. Methods We recruited adults with GPA or MPA treated with the rituximab originator or a biosimilar for ...
Arielle Mendel   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy